Mindmd.net

Qualifications/Curriculum Vitae

PERSONAL DATA
Name: David L. McCann, M.D., D.L.F.A.P.A.
4190 Highland Drive, Suite 102
Salt Lake City, UT 84124
Phone (801) 272-9205 Fax (801) 272-9208
Medical Specialty: Psychiatry. General Adult Psychiatry. Organizational and
Occupational Psychiatry. Independent Medical Evaluations.
EDUCATION
Bachelor of Science in Molecular and Genetic Biology
1962-1967
University of Utah
Salt Lake City, Utah 84112
Doctor of Medicine Degree
1967-1971
University of Maryland School of Medicine
Lombard and Green Street, Baltimore, Maryland 21218
Residency in Psychiatry
1971-1972
Duke University
Durham, North Carolina 72204
Residency in Psychiatry
1972-1974
University of Utah College of Medicine
50 North Medical Drive
Salt Lake City, Utah 84113
BOARD CERTIFICATION
Diplomate, American Board of Psychiatry and Neurology, Inc. - Psychiatry 1977
PROFESSIONAL EXPERIENCE
1974-1977 Staff Psychiatrist - V.A. Hospital, Salt Lake City, Utah
1976-Present Private Practice - Salt Lake City, Utah
1986 Adult Services Director - CPC-Olympus View Hospital, Salt Lake
City, Utah
1986-1989 Medical Director, Alcohol and Chemical Dependency Treatment -
CPC-Olympus View Hospital, Salt Lake City, Utah
1987-1989 Medical Director - CPC-Olympus View Hospital, Salt Lake City, Utah
1988-1996 Appointed Member, Utah Physician’s Licensing Board
1995 Editorial Consultant - Journal of Behavior Therapy and Experimental
Psychiatry
2004-2005 Re-appointed to Utah Physician Licensing Board
2006-2012 Governing Board, Academy of Organizational and Occupational Psychiatry
30+ years of complex Independent Medical Evaluations have been provided for a wide
variety of clients over the past 30 years or more.
PROFESSIONAL AND COMMUNITY ACTIVITIES
1980 Course Moderator, “Common Psychiatric Problems” - Annual
Scientific Meeting of the Utah State Medical Association
1980-1981 President, Utah Psychiatric Association
1982-1986 Elected Member and Chairman - Credentials Committee, St. Mark's
Hospital
1986 Executive Committee - CPC-Olympus View Hospital
1993 Site Investigator: "The Multicenter Trial for Efficacy and Safety of
Sertraline in the Treatment of Major Depression", Protocol
#R-010908. Quintiles Pacific, Inc. for Rorig Division Pharmaceuticals
Group, Pfizer, Inc.
1999 David L. McCann - “Posttraumatic Stress Disorder in the Workplace,”
Intracorp, (audience of disability, rehabilitation managers and
evaluators)
2000 David L. McCann - Psychiatric Issues in the Workplace,
Salt Lake City Corporation (presented to a multi-disciplinary
group of personnel managers)
MEMBERSHIP IN PROFESSIONAL SOCIETIES
Utah Medical Association
American Medical Association
Utah Psychiatric Association
American Psychiatric Association
Academy of Organizational and Occupational Psychiatry
Fellow - American Psychiatric Association, 1987
Distinguished Fellow, American Psychiatric Association, 2003
Distinguished Life Fellow, American Psychiatric Association, 2006
TEACHING RESPONSIBILITIES/ASSIGNMENTS
1974-2000 Clinical Instructor of Psychiatry - University of Utah School of Medicine
2000 Clinical Assistant Professor of Psychiatry - University of Utah School of
Medicine
BIBLIOGRAPHY
Publications:
McCann, David L., 1992: "Posttraumatic Stress Disorder Due to Devastating Burns
Overcome by Single Session of Eye Movement Desensitization," Journal of Behavior
Therapy and Experimental Psychiatry, Volume 23, #4.
McCann, David L., 1997: “EMDR” (1992 article published as a chapter of a book in
German.
McCann, David L., 2005: “Arbitration: Make It Work for You!”, Utah Psychiatric
Association News, Spring 2005 Issue/February.
McCann, David L., 2010: “Utah Courts Have Determined That Independent Medical
Examiners Cannot Be Sued for Malpractice”
PRESENTATIONS
David L. McCann, M.D., 1990: "Psychiatric Impairment and Chronic Soft Tissue Pain",
Rocky Mountain Center for Occupational and Environmental Health, Conference on
Managing Compensable Disability.
David L. McCann, M.D., 1992: "Antidepressants", St. Mark's Hospital Division of
Family Practitioners
David L. McCann, M.D., 1999: “EMDR, Basic Methods,” University of Utah
Neuropsychiatric Institute - presentation to medical staff
David L. McCann, M.D., 2000: “Emotional Effects of Malpractice Litigation,”
Utah Medical Insurance Association (presented to UMIA insured
physicians)
David L. McCann, M.D., February 2, 2002: “PTSD With EMDR Therapy”, University of
Utah Neuropsychiatric Institute, Psychiatric Noon Conference.
David L. McCann, M.D., August 20, 2002: “Tracking Medication to Augment Treatment”,
University of Utah Neuropsychiatric Institute, Psychiatric Noon Conference.
David L. McCann, April 9, 2003: “Practical Aspects of Living With Someone Who Has
Mental Illness, and Support for Family Members Who Have Anxiety and Depression”,
NAMI-Utah-Salt Lake City.
David L. McCann, November 2, 2004: “Trauma, PTSD, and Conversion Disorder,
Cause and Effect”, University of Utah Neuropsychiatric Institute, Psychiatric Noon
Conference.
David L. McCann, January 17, 2007: “Psychiatric Consequences of Injury –
Determination of Cause”, Workers Compensation Fund of Utah.
David L. McCann, April 15, 2007: “Posttraumatic Stress Disorder and Conversion
Disorder – Determination of Cause in the Context of Injury Claims”, AOOP 18th Annual
Meeting, Chicago, Illinois
David L. McCann, March 16, 2008: “Treating Occupational PTSD to Resolution.
Building a Traumatic Incident Intervention Program with Industry”, AOOP 19th Annual
Meeting, Chicago, Illinois
David L. McCann, November, 2011: “Postal Service Criteria for Assessing Risk for
Violence”, AOOP, 22nd Annual Meeting, Chicago, Illinois

Source: http://mindmd.net/linked/qualifications.pdf

library.usu.edu

Web of Science: Citation Indexing for Journals in All Disciplines Connect to Web of Science from the Merrill-Cazier Library website , http://library.usu.edu/. Use the “Find a Database” feature on the homepage. Or click Find Resources, then Electronic Resources & Databases , then click “W” in the alphabetical list. ƒ Combines access to Science Citation Inde

C:\program files\wercs50\docs\wercs.ps

MATERIAL SAFETY DATA SHEET Personal Protective Equipment See Section 8. 1. CHEMICAL PRODUCT AND COMPANY IDENTIFICATION Product code: Product Name: Chemical Name: 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, monohydrochloride hydrate Synonyms: 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(

Copyright © 2010-2014 Drug Shortages pdf